| Recall rate |
Percentage of screening examinations with a positive end-of-day assessment |
| Cancer detection rate |
No. of true-positive screens per 1000 screens |
| Interval cancer rate |
No. of screening examinations with a negative final assessment and cancer diagnosed within the follow-up period per 1000 screens |
| Cancer rate |
No. of screens with cancer within the follow-up period per 1000 screens |
| Biopsy recommendation rate |
No. of screening examinations with a positive final assessment per 1000 screens |
| False-positive biopsy recommendation rate |
No. of screening examinations with a false-positive final assessment per 1000 screens |
| Positive predictive value of biopsy recommendation (PPV2) |
Percentage of category 4 and 5 assessments with a tissue diagnosis of cancer within the follow-up period |
| Short-interval follow-up rate |
Percentage of screens with a final category 3 assessment |
| Sensitivity |
Percentage of true-positive results among those with cancer within the follow-up period |
| Specificity |
Percentage of true-negative results among those without cancer within the follow-up period |
